Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Study completedNCT00433550What this trial is testingIrinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel CancerWho this might be right forSmall Intestine AdenocarcinomaRecurrent Small Intestine Cancer Alliance for Clinical Trials in Oncology 33
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752875What this trial is testingLG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationWho this might be right forOvarian CancerSmall Cell Lung CancerNon Small Cell Lung Cancer+7 more LG Chem 250
Not applicableEnded earlyNCT00896467What this trial is testingPsychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial TherapyWho this might be right forAnal CancerAnxiety DisorderBreast Cancer+9 more Centre Oscar Lambret 200
Early research (Phase 1)Study completedNCT00987766What this trial is testingGemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more Vanderbilt-Ingram Cancer Center 28
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Early research (Phase 1)Ended earlyNCT05631574What this trial is testingStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerWho this might be right forNon Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more Biomea Fusion Inc. 13
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00019474What this trial is testingCombination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more Montefiore Medical Center 60
Early research (Phase 1)Ended earlyNCT02012231What this trial is testingPhase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.Who this might be right forMelanomaThyroid CancerColorectal Cancer+4 more Fore Biotherapeutics 5
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Study completedNCT03108131What this trial is testingCobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare TumorsWho this might be right forSkin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56